» Articles » PMID: 16596382

Monoallelic Deletion of the P53 Gene Through Chromosomal Translocation in a Small Cell Osteosarcoma

Overview
Journal Virchows Arch
Date 2006 Apr 6
PMID 16596382
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Small cell osteosarcoma is a rare bone tumor of high-grade malignancy that most often arises in the metaphysis of long bones in the second decade of life. Cytogenetic and molecular genetic findings in small cell osteosarcoma are poorly defined. Conventional cytogenetic analysis of a small cell osteosarcoma arising in the proximal tibia of a 9-year-old male revealed a diploid chromosomal complement with complex structural rearrangements involving chromosomes 6, 16, and 17. Immunohistochemical assessment of p53 protein expression revealed nuclear p53 immunoreactivity in approximately 15% of the neoplastic cells. Subsequent fluorescence in situ hybridization (FISH) analyses confirmed loss of the p53 gene locus on the derivative chromosome 17 homolog and were negative for amplification of the MDM2, CDK4, c-MYC, HER-2/neu, CCND1, and COPS3 gene loci. To the best of our knowledge, this represents the first demonstration of monoallelic deletion of p53 in small cell osteosarcoma, suggesting that p53 alterations may play an important role in the development of small cell osteosarcoma as well as conventional osteosarcoma.

Citing Articles

Clarifying prognostic factors of small cell osteosarcoma: A pooled analysis of 20 cases and the literature.

Zhong J, Hu Y, Si L, Geng J, Xing Y, Jiao Q J Bone Oncol. 2020; 24:100305.

PMID: 32775179 PMC: 7394919. DOI: 10.1016/j.jbo.2020.100305.


The genetics of osteosarcoma.

Martin J, Squire J, Zielenska M Sarcoma. 2012; 2012:627254.

PMID: 22685381 PMC: 3364016. DOI: 10.1155/2012/627254.


Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.

Walkley C, Qudsi R, Sankaran V, Perry J, Gostissa M, Roth S Genes Dev. 2008; 22(12):1662-76.

PMID: 18559481 PMC: 2428063. DOI: 10.1101/gad.1656808.

References
1.
Sandberg A, Bridge J . Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet. 2003; 145(1):1-30. View

2.
Nakajima H, Sim F, Bond J, Unni K . Small cell osteosarcoma of bone. Review of 72 cases. Cancer. 1997; 79(11):2095-106. DOI: 10.1002/(sici)1097-0142(19970601)79:11<2095::aid-cncr6>3.0.co;2-o. View

3.
Giovannini M, Selleri L, Biegel J, Scotlandi K, Emanuel B, Evans G . Interphase cytogenetics for the detection of the t(11;22)(q24;q12) in small round cell tumors. J Clin Invest. 1992; 90(5):1911-8. PMC: 443252. DOI: 10.1172/JCI116068. View

4.
Chandar N, Billig B, McMaster J, Novak J . Inactivation of p53 gene in human and murine osteosarcoma cells. Br J Cancer. 1992; 65(2):208-14. PMC: 1977714. DOI: 10.1038/bjc.1992.43. View

5.
Tsuchiya T, Sekine K, Hinohara S, Namiki T, Nobori T, Kaneko Y . Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet Cytogenet. 2000; 120(2):91-8. DOI: 10.1016/s0165-4608(99)00255-1. View